Treatment of Disseminated Tuberculosis

Initial Treatment Regimen

The standard 6-month four-drug regimen (isoniazid, rifampin, pyrazinamide, and ethambutol for 2 months, followed by isoniazid and rifampin for 4 months) is recommended for disseminated tuberculosis without central nervous system involvement, according to the American Thoracic Society 1, 2
For patients with disseminated TB without CNS involvement, the intensive phase (first 2 months) should include isoniazid, rifampin, pyrazinamide, and ethambutol daily, as recommended by the American Academy of Family Physicians 3
The continuation phase (next 4 months) for patients with disseminated TB without CNS involvement should include isoniazid and rifampin daily or 2-3 times weekly under directly observed therapy, as recommended by the American Academy of Family Physicians 3

For disseminated TB with CNS involvement, treatment must be extended to 9-12 months with isoniazid, rifampin, pyrazinamide, and a fourth drug (streptomycin, ethambutol, or ethionamide) for at least the first 2 months, according to the American Thoracic Society 1, 2, 3
Corticosteroids (60 mg/day initially, tapering over several weeks) should be added for stages II and III meningitis, as recommended by the American Thoracic Society 1, 2

Children with disseminated TB should be treated for 9-12 months regardless of CNS involvement due to higher risk of dissemination, according to the Centers for Disease Control and Prevention 3, 4, 5
The same drugs used in adults (isoniazid, rifampin, pyrazinamide, and ethambutol) should be used in children with adjusted dosing, as recommended by the American Thoracic Society 1
Ethambutol should be avoided in children <6 years whose visual acuity cannot be monitored; streptomycin should be substituted instead, according to the Centers for Disease Control and Prevention 4, 1
HIV-infected patients with disseminated TB should have their treatment duration extended to 9 months minimum and at least 6 months after sputum conversion, as recommended by the American Academy of Family Physicians and the Centers for Disease Control and Prevention 3, 4, 5
Once-weekly isoniazid-rifapentine should be avoided in the continuation phase for HIV-infected patients, according to the American Academy of Family Physicians 3
Twice-weekly dosing should not be used if CD4+ count <100 cells/mm³, as recommended by the American Academy of Family Physicians 3

Isoniazid, rifampin, and ethambutol should be used as the preferred initial regimen for pregnant women with disseminated TB, according to the Centers for Disease Control and Prevention 4, 5
Streptomycin should be avoided in pregnant women due to the risk of congenital deafness, as recommended by the Centers for Disease Control and Prevention 4, 5
Pyrazinamide should not be used routinely in pregnant women due to inadequate teratogenicity data, according to the Centers for Disease Control and Prevention 4
Breastfeeding is safe during treatment for disseminated TB, as recommended by the American Academy of Family Physicians and the Centers for Disease Control and Prevention 3, 4

Directly observed therapy (DOT) should be implemented for all patients with disseminated TB to ensure adherence and prevent resistance, according to the American Journal of Respiratory and Critical Care Medicine and the Centers for Disease Control and Prevention 6, 4, 5
DOT should be performed by a healthcare provider or designated person, according to the Centers for Disease Control and Prevention 4, 5
DOT is particularly critical for HIV-infected patients and those with drug-resistant disease, as recommended by the Centers for Disease Control and Prevention 4, 5

Monthly clinical monitoring should be performed for drug toxicity and treatment response, according to the American Journal of Respiratory and Critical Care Medicine 6
Clinical improvement should be assessed by 3 months; if absent, reevaluation for drug resistance or non-adherence should be performed, according to the American Journal of Respiratory and Critical Care Medicine 6
HIV testing and counseling should be offered to all TB patients, as recommended by the American Journal of Respiratory and Critical Care Medicine 6

Failing to perform lumbar puncture in miliary TB can lead to under-treatment if meningitis is present, resulting in poor outcomes, according to the American Thoracic Society 1, 2
Premature discontinuation of treatment can occur if completion is determined by duration rather than number of doses taken, according to the American Academy of Family Physicians 3
Using ethambutol in young children can result in irreversible optic neuritis when visual monitoring is impossible, according to the Centers for Disease Control and Prevention and the American Thoracic Society 4, 1
Inadequate treatment of HIV co-infected patients can occur if the standard 6-month regimen is used; treatment should be extended to 9 months minimum, as recommended by the American Academy of Family Physicians and the Centers for Disease Control and Prevention 3, 4, 5